Literature DB >> 9584375

Adjunct low intensity ultrasound in Charcot neuroarthropathy.

E Strauss1, G Gonya.   

Abstract

Neuropathic arthropathy or Charcot joint is a disease process that results in progressive destruction of bone and soft tissue secondary to the loss of protective sensation. The disease is most common among patients suffering from diabetes mellitus. Although there is no known definitive cure for the progressive destruction of a Charcot joint, it is possible to slow and in some cases arrest the destruction of the bone and soft tissue. The Charcot joint will be addressed with a review of the literature and use of a new technology as adjunct treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9584375     DOI: 10.1097/00003086-199804000-00016

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  The Charcot foot: medical and surgical therapy.

Authors:  Jan S Ulbrecht; Dane K Wukich
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

2.  Arthroplasty of a Charcot knee.

Authors:  Sina Babazadeh; James D Stoney; Keith Lim; Peter F M Choong
Journal:  Orthop Rev (Pavia)       Date:  2010-09-23

3.  The Charcot foot in diabetes.

Authors:  Lee C Rogers; Robert G Frykberg; David G Armstrong; Andrew J M Boulton; Michael Edmonds; Georges Ha Van; Agnes Hartemann; Frances Game; William Jeffcoate; Alexandra Jirkovska; Edward Jude; Stephan Morbach; William B Morrison; Michael Pinzur; Dario Pitocco; Lee Sanders; Dane K Wukich; Luigi Uccioli
Journal:  Diabetes Care       Date:  2011-09       Impact factor: 19.112

4.  An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy.

Authors:  Crystal L Ramanujam; Zacharia Facaros
Journal:  Diabet Foot Ankle       Date:  2011-05-11

5.  Pathological fracture of the femur in Alagille syndrome that was treated with low-intensity pulsed ultrasound stimulation and an Ilizarov ring fixator: a case report.

Authors:  Koji Nozaka; Yoichi Shimada; Naohisa Miyakoshi; Shin Yamada; Yuji Kasukawa; Atsuko Noguchi
Journal:  BMC Musculoskelet Disord       Date:  2014-07-08       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.